Related Experiment Videos
Uric acid levels in sera from patients with multiple sclerosis
J Drulović1, I Dujmović, N Stojsavljević
1Institute of Neurology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Dr Subotića 6, Belgrade 11000, Yugoslavia. chcondru@EUnet.yu
Journal of Neurology
|April 4, 2001
Summary
Serum uric acid (UA) levels were lower in active multiple sclerosis (MS) patients. Lower UA correlates with MS disease activity and duration, suggesting UA may indicate MS progression and benefit from antioxidant therapies.
Area of Science:
- Neuroimmunology
- Biochemistry
Background:
- Uric acid (UA) is a natural peroxynitrite scavenger.
- Multiple Sclerosis (MS) is a chronic neurological disease with inflammatory and neurodegenerative components.
Purpose of the Study:
- To investigate serum uric acid levels in patients with multiple sclerosis (MS).
- To explore the correlation between uric acid levels and MS disease activity, duration, and disability.
Main Methods:
- Serum samples were collected from 240 MS patients and 104 controls with other neurological diseases (OND).
- Serum uric acid concentrations were measured and analyzed in relation to disease status (active vs. inactive MS) and clinical parameters.
- Multivariate linear regression was used to identify independent predictors of serum UA levels.
Main Results:
- Mean serum UA was lower in MS patients than OND controls, though not statistically significant.
- Active MS patients had significantly lower serum UA levels compared to inactive MS patients and OND controls.
- Serum UA showed significant inverse correlations with female gender, MS disease activity, and disease duration.
Conclusions:
- Serum uric acid may serve as a potential biomarker for multiple sclerosis disease activity.
- Lower uric acid levels in MS patients suggest a role for oxidative stress and support the investigation of radical-scavenging therapies.